Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-025453
Filing Date
2017-11-06
Accepted
2017-11-06 19:03:13
Documents
1
Period of Report
2017-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13317
  Complete submission text file 0000899243-17-025453.txt   14748
Mailing Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVENUE, SUITE 104 LARCHMONT NY 10538
Business Address
Kraus Stephen (Reporting) CIK: 0001362099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38268 | Film No.: 171180742

Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

EIN.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)